Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 August, 2018 19:57 IST
Cipla gets USFDAs final approval for generic Isuprel
Source: IRIS | 14 Jun, 2018, 10.36AM
Comments  |  Post Comment

Cipla, announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, single-use sterile Ampoule from the United States Food and Drug Administration (US FDA).

Cipla's Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, ampoule is APrated generic therapeutic equivalent version of Hospira Inc's Isuprel Injection, 0.2mg/ml and is indicated for the treatment of…

> Mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.

> Serious episodes of heart block and Adams-Stokes attacks (except when caused by ventricular tachycardia or fibrillation).

> Use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, is available.

> Bronchospasm occurring during anesthesia.

> As an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure, and cardiogenic shock.

According to IQVIA (IMS Health), Isuprel Injection and its generic equivalents had US sales of approximately USD 148M for the 12-month period ending April 2018.

Shares of the company gained Rs 18.9, or 3.33%, to trade at Rs 585.95. The total volume of shares traded was 75,241 at the BSE (10.22 a.m., Thursday).





Cipla Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Zensar Technologies signs global OEM partnership with PTC - 21-Aug-2018 16:19
Nestle India partners with Flipkart to launch Maggi special masala noodles - 21-Aug-2018 16:13
Lupin launches generic Clobetasol propionate cream in US - 21-Aug-2018 16:05
Jet Airways expands codeshare agreement with Bangkok airways - 21-Aug-2018 11:46
Man Infraconstruction intimates of arbitral award in favour of subsidiary Manaj Tollway - 21-Aug-2018 10:44
Lupin receives USFDA nod for generic Hydrocortisone Butyrate lotion - 21-Aug-2018 10:36
Tanla Solutions acquires Karix Mobile for Rs 3.40 bn - 21-Aug-2018 09:31
Indian Hume Pipe Co bags work order worth Rs 2.56 bn - 20-Aug-2018 16:17
Multi Commodity Exchange of India signs MoU with Indian Cotton Federation - 20-Aug-2018 16:12
Ratnamani Metals & Tubes wins orders worth Rs 1.55 bn - 20-Aug-2018 10:00
Ion Exchange receives EPC contract worth Rs 4.38 bn - 17-Aug-2018 11:35
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer